Sensex, Nifty may still have some steam left: Monday closing report

The indices have become overbought on a short-term basis but may head higher

The Indian markets carried forward the positive momentum of Friday and shot up at the open and traded high for the entire trading session on Monday. Ahead of the result of the exit polls today, the market surged anticipating the BJP-led NDA to be able to gain a majority. Narendra Modi, the prime ministerial candidate from the NDA, is perceived as being more business-friendly and decisive by the market players.

The BSE 30-share Sensex opened at 23,031 while the NSE 50-share Nifty opened at 6,863.40.  By the end of the session, both the indices hit their days high and closed near to it. In the last hour of the session, Sensex and the Nifty managed to cross the level of 23,500 and 7,000 and stayed above that level until the end of the session. Sensex hit a high of 23,573 and closed at 23,551 (up 557 points or 2.42%) while Nifty hit a high of 7,020 and closed at 7,014 (up 155 points or 2.27%). The NSE recorded a higher volume of 97.68 crore shares. India VIX closed lower at 37.1050 (fell 1.59%).

Except for Pharma (0.89%) all the other indices on the NSE closed in the green. The top five gainers were CPSE (3.98%), PSE (3.25%), Energy (3.05%), Media (3.00%) and Infra (2.95%).

Of the 50 stocks on the Nifty, 43 ended in the green. The top five gainers were Coal India (6.11%), Power Grid (5.29%), Grasim (4.75%), HDFC Bank (4.64%) and Hero MotoCorp (4.14%). The top five losers were United Spirits (2.72%), Sun Pharma (1.46%), Cipla (1.12%), Hindalco (1.01%) and Jindal Steel (0.65%).

Of the 1,578 companies on the NSE, 756 companies closed in the green, 737 companies closed in the red while 85 companies closed flat.

Coal India (up 7.04%) was the top gainer in Sensex 30 pack. The company was in news for its board may consider the issue of awarding contract for coal import in a meeting likely to be held by the month-end.

Cipla (fell 1.26%) was among the top two loser in the Sensex 30 stock. Cipla today said it will invest $1.5 million to acquire 14.6% stake in US-based Chase Pharmaceuticals engaged in developing novel approaches to improve treatments for Alzheimer’s disease.

Torrent Power (up 18.38%) was the top gainer in the ‘A’ group on the BSE. The company has announced that it is planning a re-organisation of power sector operations of Torrent Group. Corporation Bank (down 4.95%) was the biggest lose in the ‘A’ group on the BSE. The bank’s annual result showed fall in the net profit for the financial year ended 2014.

India's merchandise exports rose 5.26% to $25.63 billion in April 2014 over April 2013, data released by the government after trading hours on Friday, 9 May 2014, showed.
Imports dropped 15% at $35.72 billion in April 2014 over April 2013. The trade deficit for April 2014 was estimated at $10.09 billion, which was sharply lower than the trade deficit of $17.67 billion during April 2013.

The government unveils CPI data for April 2014 after trading hours today, 12 May 2014. US indices closed marginally in the green on Friday.

Asian indices had a mixed performance. Shanghai Composite (up 2.08%) was the top gainer. Both Straits Times and Taiwan Weighted fell 0.91% were the top loser.

Japan's current-account surplus narrowed more than forecast in March as a surge in imports before last month's sales-tax increase trimmed gains from overseas investments. The excess of 116.4 billion yen ($1.14 billion) reported today by the Ministry of Finance in Tokyo. A 782.9 billion yen deficit on a seasonally adjusted basis was the largest in comparable data back to at least 1996.

European indices were trading in the green. US indices were trading higher.


The Next India: Opportunities and challenges

A steady pace of implementation of policy reforms can lay foundation of India's read GDP at an average of 6.75%, and the economy would pass the $5 trillion mark over the next 10 years, says Morgan Stanley

The effects of corrective policy measures in India during the past 12 months in the form of adjustments in the real effective exchange rate and real interest rates, and steps to improve the business environment alongside the steady improvement in the external environment, are beginning to show in improving macro stability indicators. Stock markets have responded as well, and there is growing evidence that the market believes in a new growth cycle – the most pertinent signal being the widening gap between bond and equity yields, says Morgan Stanley in a research note.


Morgan Stanley said, it believes that India’s medium-term growth trend will be supported by the inter-play of the structurally positive factors of demographics like strong growth in the working age population, reforms that can help improve productivity and globalisation accelerating productive job opportunities, income and saving. "In the coming 12 months, as policy makers focus on maintaining improvement in macro stability indicators, particularly inflation, we believe that the growth recovery will remain somewhat slow."


"However," the report says, "we believe the cumulative impact of sustained policy measures to improve investment sentiment for domestic and foreign entrepreneurs will begin to support a more meaningful acceleration in gross domestic product (GDP) growth from FY2016 onwards. This will likely lead to a new profit cycle in FY2016, as well as a greater appetite for equities among domestic investors. We believe that domestic households could end up buying in excess of $230 billion of stocks by FY2025, as compared to $40 billion in the past 10 years."

Source: Morgan Stanley


According to Morgan Stanley, two key variables that will be critical in reviving India’s growth trend are improvement in the external environment and a pick up in the pace of structural reforms. The global economics team at Morgan Stanley expects global growth to improve further to 3.7% in 2015, moving closer to the last 30 years’ average, giving it the confidence that the external environment will be supportive of India’s growth recovery.


However, policy reforms at home would be even more critical, the report cautions. Over the past five years, the Indian government’s policy was focused more on redistribution and less on boosting productive income growth. Moreover, bureaucratic hurdles and corruption-related investigations have exacerbated the challenges of weak demand and low corporate confidence. This has held back the much needed capex cycle and has been a drag on economic growth, it added.


The reports says, overhauling bureaucratic processes and enacting reforms to lift sustainable growth is imperative. It says, "The macro stability risks of higher inflation, a wide current account deficit and asset quality issues in the banking system associated with such a policy approach has forced a recognition among policy makers of the need to pay greater attention to reviving the productive dynamic."


Morgan Stanley feels that to generate productive employment opportunities for India’s large and growing working age population, higher economic growth rates are needed. Moreover, India’s literate and well-connected middle class is now reaching critical mass, it added.

According to the report, India’s relatively lower Gini coefficient as compared with other large emerging market economies indicates that the fruits of higher income growth have been shared relatively evenly across a larger segment of the population and, hence, have supported the rise of the middle class. "As we have seen in other major Asian economies, this middle class will demand greater accountability of policy makers to deliver on reforms that revive the virtuous dynamic of productive jobs – income growth – savings – investment," the report said.


In its base case, Morgan Stanley expects a steady pace of implementation of policy reforms, which will lay the foundations for India’s real GDP growth to move higher to an average of 6.75% over the next 10 years. It said, "If our projections were to come to fruition, India’s economy would pass the $5 trillion dollar mark, a feat that has been achieved by only the US and China thus far and would make India the fifth-largest economy from 10th currently in the world. Accordingly, India’s consumption and investment opportunities would rise to 3.6 trillion and $1.9 trillion, respectively."

Morgan Stanley feels India's strong macro story also means money-making opportunities for stock market investors. According to the research note, there are three themes for this...

1) the macro story leading to the next profit boom – Morgan Stanley said it expect profit growth to average 14.6% over the coming decade

2) the drivers for the rising household ownership of equities, given that equities could compound between 12% and 15% over the coming decade in local currency terms; and, ultimately,

3) India will remain a portfolio manager's delight because of its intense stock-picking characteristics and, ultimately, how all this translates into stock market returns, which will likely make India one of the biggest equity markets in the world.

However, Morgan Stanley cautions about the challenges and risk in the journey towards $5 trillion GDP and $4 trillion market cap. It says, "We see three reasons why this is the case. First, while we have assumed that the global growth environment will be benign and supportive for India, there remain considerable risks to this outlook, as the advanced economies will still have to deal with the challenges associated with de-leveraging, while the emerging markets will have to contend with the challenges associated with a change in their growth models. Second, closer to home, implementing the needed reforms will require a stable political environment that is geared towards providing a reformist push to achieve sustainable higher growth rates. Third, the list of reforms is long and, in some cases, will be difficult to implement in a timely fashion, as consensus will need to be built and vested interests overcome. Overhauling bureaucratic processes and installing transparent mechanisms for allocation of resources and projects, which is critical for kick-starting the capex cycle and infrastructure development, will also be a time-consuming endeavour."

"In addition, there are specific risks to equity returns, including a shrinking free float for foreign investors, evolving corporate governance standards, acute dependence on foreign capital, which causes extreme stock market volatility, and negative real rates," Morgan Stanley added.


Cipla invests $1.5 million for 14.6% stake in Chase Pharmaceuticals

The  $21  million  two-phase  financing  from Cipla will  support  Phase  2a and  Phase  2b clinical  trials  for Chase’s lead drug CPC201

Cipla Ltd said it invested $1.5 million for buying a 14.6% stake in US-based Chase Pharmaceuticals Corp. The investment will be done through Cipla's UK subsidiary Cipla (EU) Ltd.

In a regulatory filing, the pharmaceutical company said, Chase has a unique patented approach and is focused on improving the efficacy, safety and tolerability of existing Alzheimer medications.

The  $21  million  two-phase  financing  will  support  Phase  2a and  Phase  2b clinical  trials  for Chase’s lead drug CPC201. The original venture funding for Chase was provided by the Brain Trust Accelerator Fund in 2010, Cipla said in the filing.

“This investment is consistent with Cipla New Ventures’ mission to build more innovation-led business streams for Cipla in the future. We want to bring affordable medicines, where we identify an unmet patient need, in a way that leverages Cipla’s formidable technology, device and development capabilities, ” Subhanu Saxena, managing director and global chief executive of Cipla said.

In  India,  over  5  million  patients  suffer  from  dementia,  most  of  whom  are  afflicted  with Alzheimer’s. These numbers are expected to double by 2030. In India, the caregiver  is the family and  the  economic  and  social  impact  is  far  reaching.  In  North America,  Alzheimer’s disease affects more than over 7 million patients and its impact is growing as the population ages.  The  disease  costs  the  US  alone  $203  billion  annually  with  projections  to  reach  $1.2 trillion by 2050.

Cipla said, in addition to financing Chase, it will collaborate with the company to develop the drug. If successful, Cipla may provide low cost access to Chase’s lead drug in India and South Africa, the company added.

Cipla closed Monday 1.3% up at Rs387 on the BSE while the 30-share Sensex ended the day 2.2% higher at 23,494.


We are listening!

Solve the equation and enter in the Captcha field.

To continue

Sign Up or Sign In


To continue

Sign Up or Sign In



The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)